CID Capital

About The Fund

InterWest Partners is a venture capital firm with a significant history and focus on investing in early-stage information technology (IT) and healthcare startups. For over 40 years, InterWest has been partnering with entrepreneurial teams to build successful companies. The firm's investment strategy revolves around identifying and nurturing innovative businesses with the potential for high growth and market leadership. InterWest typically invests in companies that are developing novel technologies or solutions that can disrupt existing markets or create new ones. With $2.8 billion in assets under management across ten funds, InterWest has a substantial track record that includes 97 IPOs and 95 upside acquisitions. Some of their notable past investments include Xilinx in semiconductors, CIENA in telecommunications, COR Therapeutics in biotechnology, and Ventritex in medical devices. More recently, their final fund, IW10, saw significant returns from investments in companies such as Doximity, Canva, Braze, Tesaro, C3.ai, Glaukos, and Labrys. Despite their past activity and success, InterWest is not currently seeking new investments. Their expertise areas include software, web, marketplace, SaaS, hardware, manufacturing, logistics, and distribution. They cater to various stages of business development ranging from seed to later-stage expansions, with a particular interest in startups and early-stage companies. InterWest has been known to invest capital ranging from $7 million to $15 million in their portfolio companies, with their headquarters situated at 2710 Sand Hill Road, Suite 200, Menlo Park, California.